Free Trial

Merck KGaA (OTCMKTS:MKGAF) Shares Gap Down - Here's Why

Merck KGaA logo with Medical background

Key Points

  • Merck KGaA's stock price gapped down significantly, opening at $123.32 after closing at $131.17 the previous day.
  • The company has a current market capitalization of $16.14 billion, with the shares trading down 4.8% to $127.51 during the session.
  • Merck KGaA operates in sectors including Life Science, Healthcare, and Electronics, providing tools and equipment for various industries.
  • MarketBeat previews top five stocks to own in October.

Merck KGaA (OTCMKTS:MKGAF - Get Free Report)'s stock price gapped down before the market opened on Thursday . The stock had previously closed at $131.17, but opened at $123.32. Merck KGaA shares last traded at $127.51, with a volume of 318 shares.

Merck KGaA Trading Down 4.8%

The company has a market cap of $16.14 billion, a price-to-earnings ratio of 19.07 and a beta of 0.96. The business's fifty day moving average price is $129.23 and its 200 day moving average price is $132.91. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84.

About Merck KGaA

(Get Free Report)

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Merck KGaA Right Now?

Before you consider Merck KGaA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Merck KGaA wasn't on the list.

While Merck KGaA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.